Read More

What’s Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

AKRO

Read More

Snowflake CEO Targets AI Acquisitions To Boost Growth: Report

Snowflake Inc's new CEO, Sridhar Ramaswamy, is focusing on AI acquisitions to compete with rivals like Databricks and major cloud companies. Despite failing to purchase Reka AI, Snowflake is integrating AI talent, including 35 employees from TruEra. Ramaswamy aims to boost revenue growth through strategic AI investments, crucial as sales growth slows.

AMZN